Cannabinoid News and Research

Latest Cannabinoid News and Research

Cannabis-based medication helps tackle dependency on cannabis

An Australian study has demonstrated that cannabis-based medication helps tackle dependency on cannabis, one of the most widely used drugs globally.

16 Jul 2019

Researchers study cannabis dosage to reduce seizures in children with severe epilepsy

Medicinal cannabis oil containing both cannabidiol and a small amount of THC can reduce or end seizures in children with severe, drug-resistant epilepsy, a study by the University of Saskatchewan, Canada has found.

8 Jul 2019

Cannabis use during pregnancy may cause premature birth

Pregnant women should refrain from smoking cannabis to prevent their infants from being born early, a new study warns.

8 Jul 2019

Creating a physical and genetic map of Cannabis sativa

Scientists have developed a physical and genetic map of Cannabis sativa to facilitate further investigation into the genetic and molecular mechanisms exhibited by this plant.

19 Jun 2019

Case study: Cannabinoid hyperemesis syndrome in a patient with ALS

This case study of a patient with ALS and symptoms of cannabinoid hyperemesis syndrome emphasizes the need for research into the use of medicinal cannabis.

12 Jun 2019

Body's endocannabinoid system appears to be new target for drug development against OCD

The body's endocannabinoid system, due to the critical role it plays in regulating neurotransmitter signaling, is an enticing target for drug development against disorders associated with anxiety, stress, and repetitive behaviors, such as obsessive-compulsive disorder.

3 Jun 2019

Cannabis could help people with opioid addiction

A new study has shown that cannabidiol or CBD, found in cannabis, could help people with opioid use disorder or addiction. CBD can help reduce the symptoms of craving among addicts when on withdrawal from the opioid and also reduce the accompanying anxiety and restlessness write the authors of the study.

22 May 2019

Cannabidiol reduces cue-induced craving and anxiety in individuals with history of heroin abuse

Cannabidiol reduced cue-induced craving and anxiety in individuals with a history of heroin abuse, suggesting a potential role for it in helping to break the cycle of addiction, according to research conducted at the Icahn School of Medicine at Mount Sinai and published May 21 in the American Journal of Psychiatry.

21 May 2019

Microextraction gets an eco-friendly makeover in new cannabis study

Researchers have successfully demonstrated that IT-SPME coupled to nano-LC is an adequate analytical method for the characterization of cannabis traces.

15 May 2019

Which type of chromatography is best for cannabis analysis?

Cannabis analysis is essential, but which technique is better? A comprehensive report details the most widely used analytical techniques between 2015-2018.

9 May 2019

The endocannabinoid system and skin conditions

a significant amount of research over the past 20 years has demonstrated that the endocannabinoid system plays a vital role in skin homeostasis, and therefore skin conditions too.

7 May 2019

New insight into fast-growing retail and medicinal cannabis industry

Edison Group, the leading investment and research advisory company, has published its sector report analyzing the growing retail and medicinal cannabis industry.

3 May 2019

Cannabis, Alcohol and the Epigenome

With the legalization of cannabis in many US states, we explore the epigenetic effects of cannabis, cannabis-derived products, and alcohol.

29 Apr 2019

CBD could help slip medications into the brain

Cannabidiol, a non-psychoactive compound in cannabis, is being touted as beneficial for many health conditions, ranging from anxiety to epilepsy.

17 Apr 2019

Don't Believe the Hemp: UHPLC Analysis of Hemp Seed Oils

Despite the popularity of hemp seed oil products, there are currently no standardized analysis techniques. To this end, researchers have been exploring the use of HPLC-MS for cannabinoid profiling of hemp.

10 Apr 2019

Online cannabis oils contain dangerous amounts of psychoactive THC

Scientists have published a review in the BMJ which calls for more research and regulations surrounding CBD oils offered by online sellers, after it was found that most contain the psychoactive ingredient THC.

8 Apr 2019

Clinical review offers advice for doctors in prescribing cannabinoids for certain conditions

A clinical review, published today for the BMJ, provides new interim advice for doctors and clinicians in prescribing cannabis-based products and cannabinoids to treat certain conditions.

8 Apr 2019

Scientists develop new accurate computational method to enhance drug target stability

Scientists from the Moscow Institute of Physics and Technology, the Skolkovo Institute of Science and Technology, and the University of Southern California have developed a new computational method for the design of thermally stable G protein-coupled receptors that are of great help in creating new drugs.

30 Mar 2019

Clinical trial examines medicinal cannabis as potential treatment for severe Tourette syndrome

A pioneering clinical trial investigating medicinal cannabis as a potential treatment for people living with severe Tourette syndrome will be conducted by Wesley Medical Research, in Brisbane in Australia, with cannabis supply facilitated by Lambert Initiative for Cannabinoid Therapeutics at University of Sydney.

28 Mar 2019

Sativa Investments completes 1000th cannabinoid and terpenes test at PhytoVista Laboratories

Sativa Investments PLC, the UK’s first medicinal cannabis investment vehicle, has completed its 1000th cannabinoid and terpenes test at its on-site testing facility, PhytoVista Laboratories (“PhytoVista”).

25 Mar 2019